Sandbox:patho2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 10: | Line 10: | ||
:* Nerve tissues in the neck (1-5% of the cases) | :* Nerve tissues in the neck (1-5% of the cases) | ||
:* Nerve tissues in the pelvis (2-3% of the cases) | :* Nerve tissues in the pelvis (2-3% of the cases) | ||
* Neuroblastoma cells | * Neuroblastoma tumor cells secrete catecholamines such as: | ||
:* Vanillylmandelic acid (VMA) | :* Vanillylmandelic acid (VMA) | ||
:* Homovanillic acid (HVA) | :* Homovanillic acid (HVA) | ||
Line 43: | Line 43: | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
* On microscopic histopathological analysis | * On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma. | ||
* Other findings of neuroblastoma on | * Other findings of neuroblastoma on light microscopy may include: | ||
:* Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center) | :* Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center) | ||
:* Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance) | :* Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance) | ||
* On electron microscopy neuroblastoma is characterized by: | |||
:* Dendritic processes with longitudinally oriented microtubules | |||
:* Membrane bound electron-dense granules that contain catecholamines | |||
:* Presence of desmosomes | |||
:* Absence of glycogen | |||
* On immunohistochemistry neuroblastoma is characterized by: | |||
:* Protein gene product (PGP) 9.5 positivity | |||
:* Monoclonal antibody NB84 positivity | |||
:* Synaptophysin positivity | |||
:* CD99 marker negativity | |||
* Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: schwannian stroma rich group and a schwannian stroma poor group as illustrated below:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref><ref name="pmid11745303">{{cite journal| author=Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al.| title=International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. | journal=Cancer | year= 2001 | volume= 92 | issue= 9 | pages= 2451-61 | pmid=11745303 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11745303 }} </ref> | |||
<br> | |||
{{Family tree/start}} | |||
{{familytree | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">''' Neuroblastic tumors'''</div>}} | |||
{{familytree | | |,|-|^|-|.| | | | | | | | }} | |||
{{familytree | | X01 | | X02 | | | | | | |X01='''Schwannian stroma rich group'''| X02='''Schwannian stroma poor group'''}} | |||
{{familytree|boxstyle= border-top: 0px;| | A01 | | A03 | | | | | | |A01=<div style="width: 20em; padding:1em;"> | |||
'''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;">|A03=<div style="width: 20em; padding:1em;"> | |||
'''Nodular ganglioneuroblastoma'''<br>'''Intermixed ganglioneuroblastoma'''<br>'''Maturing ganglioneuroma'''<br>'''Mature ganglioneuroma''' </div>}} | |||
{{Family tree/end}} | |||
<br> | |||
* Based on the degree of the cellular maturity and composition, neuroblastoma may be further classified into three subtypes according to the International Neuroblastoma Pathology Classification which include:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref> | |||
:* Undifferentiated neruoblastoma | |||
:* Poorly differentiated neuroblastoma | |||
:* Differentiating neuroblastoma | |||
* The table below summarizes the differnces between the three histological subtypes of neurublastoma:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref> | |||
{| | |||
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Risk Factor''' | |||
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Undifferentiated neruoblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" | Completely formed by neuroblasts with no maturity of ganglion cells | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Poorly differentiated neuroblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" |Mostly formed by neuroblasts with less the 5% maturing ganglion cells | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Differentiating neuroblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
Predominantly formed by neuroblasts but with more than 5% mature ganglion cells | |||
|} | |||
* Shown below is a series of microscopic images of different subtypes of meningioma: |
Revision as of 01:19, 6 October 2015
Pathogenesis
- Neuroblastoma arises from neural crest cells, which are normally involved in the development of the sympathetic nervous system and adrenal glands.
- Neuroblastoma is frequently observed along the sympathetic nervous system structures. Specific sites may include:
- Adrenal glands (35% of the cases)
- Retroperitoneal organs (30% of the cases):
- Organ of Zuckerkandl
- Coeliac axis
- Paravertebral sympathetic chain
- Posterior mediastinum (20% of the cases)
- Nerve tissues in the neck (1-5% of the cases)
- Nerve tissues in the pelvis (2-3% of the cases)
- Neuroblastoma tumor cells secrete catecholamines such as:
- Vanillylmandelic acid (VMA)
- Homovanillic acid (HVA)
- Neuroblastoma may demonstrate spontaneous regression from an undifferentiated state to a completely benign cellular state.
Genetics
- Development of neuroblasotma is the result of multiple genetic mutations.
- The vast majority of neuroblastoma cases are sporadic.
- 1-2% of neuroblastoma cases may demonstrate a familial predilection.
- Genes involved in the pathogenesis of neuroblastoma include:
- NBPF10 gene chromosome 1
- KIF1B gene on chromosome 1
- ALK gene on chromosome 2
- LMO1 gene on chromosome 11
- PHOX2A gene on chromosome 11
- MYCN oncogene amplification is a common finding among neuroblastoma patients.
Associated Conditions
- Neuroblastoma is associated with a number of syndromes that include:
- Neurofibromatosis type 1 syndrome (von Recklinghausen disease)
- Beckwith-Wiedemann syndrome
- DiGeorge syndrome
- Hirschsprung disease
Gross Pathology
- On gross pathology, a well defined, bulky, and tan colored mass is a characteristic finding of neuroblastoma.
- Other associated findings of neuroblastoma on gross pathology may include:
- Fibrous pseudocapsule
- Necrosis
- Hemorrhage
- Calcification
Microscopic Pathology
- On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
- Other findings of neuroblastoma on light microscopy may include:
- Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center)
- Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
- On electron microscopy neuroblastoma is characterized by:
- Dendritic processes with longitudinally oriented microtubules
- Membrane bound electron-dense granules that contain catecholamines
- Presence of desmosomes
- Absence of glycogen
- On immunohistochemistry neuroblastoma is characterized by:
- Protein gene product (PGP) 9.5 positivity
- Monoclonal antibody NB84 positivity
- Synaptophysin positivity
- CD99 marker negativity
- Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: schwannian stroma rich group and a schwannian stroma poor group as illustrated below:[1][2]
Neuroblastic tumors | |||||||||||||||||||||||||||||
Schwannian stroma rich group | Schwannian stroma poor group | ||||||||||||||||||||||||||||
Undifferentiated neuroblastoma Poorly differentiated neuroblastoma Differentiating neuroblastoma |
Nodular ganglioneuroblastoma Intermixed ganglioneuroblastoma Maturing ganglioneuroma Mature ganglioneuroma | ||||||||||||||||||||||||||||
- Based on the degree of the cellular maturity and composition, neuroblastoma may be further classified into three subtypes according to the International Neuroblastoma Pathology Classification which include:[1]
- Undifferentiated neruoblastoma
- Poorly differentiated neuroblastoma
- Differentiating neuroblastoma
- The table below summarizes the differnces between the three histological subtypes of neurublastoma:[1]
Risk Factor | Description |
---|---|
Undifferentiated neruoblastoma | Completely formed by neuroblasts with no maturity of ganglion cells |
Poorly differentiated neuroblastoma | Mostly formed by neuroblasts with less the 5% maturing ganglion cells |
Differentiating neuroblastoma |
Predominantly formed by neuroblasts but with more than 5% mature ganglion cells |
- Shown below is a series of microscopic images of different subtypes of meningioma:
- ↑ 1.0 1.1 1.2 Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
- ↑ Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.